2018/19 | OX1 Incubator

Meet the Cohort 2018/19

Operon (formerly Coli)

Multiplatform lab work management application

Operon aims to improve the efficiency of science with software. Science is held back by the way scientists manage their lab work. Operon is a multiplatform ELN application to easily set up, execute and record experiments from the desktop to the bench-top. Unlike competitors, it is both easy-to-use and ready for bench-top integration.

Reza Rohani

(Team Lead)

PhD Bioengineering

2018-19 cohort-01.png

Serbald Verkuijl

(Product)

PhD Interdisciplinary Biosciences

2018-19 cohort-02.png

Stefan Leape (Business)

MSc Biochemistry undergraduate

AllGood

Elderly care app that helps you checks on loved ones

AllGood was founded on the belief that families shouldn't have to worry about their elderly loved ones living alone. All current solutions entail functional, emotional, and economic compromises. As 40% of seniors have a smartphone, AllGood decided to solve this problem with a simple mobile application. It provides an alternative to obsolete panic buttons (of which half are never worn).

2018-19 cohort-03.png

Maggie Chen

MPhil Languages undergraduate

2018-19 cohort-04.png

Carlo Quadrio Curzio

BA Human Sciences

2018-19 cohort-05.png

Benjamin Griffiths

DPhil Quantum Physics

Daniel Ma

BSc Computer Science

Neurolytics (formerly Rebndl)

Intelligent digital news subscription

Rebndl is on the verge of transforming the news publishing industry. Currently, 67% of people read the news online for free, and are increasingly looking to access a highly curated selection of news stories on their smartphones. Through its digital news subscription platform, Rebndl integrates the emerging trends in news consumption behaviour with the changing business demands of newspapers to shape the future of news publishing.

After having been equipped with the skills needed to found a start-up in the OX1 Incubator, the original Rebndl team moved on to a new idea: Neurolytic Healthcare Ltd. They have already received funding from two sources and have a headcount of 10 dedicated team members including a prominent advisory board.

Neurolytic Healthcare Ltd. delivers AI-driven real-time event prediction and pharmacogenomic testing for neurological disorders to improve patient quality of life and help clinicians optimise prescription decisions. It draws on recent advances and successes in personalised medicine and pharmacogenomics, supported by NHS England's aim to embed personalised healthcare across the NHS. Given the current suboptimal management of neurological disorders and lack of specialised healthcare staff in the UK, there remains a significant unmet need for digital healthcare providers who can deliver effective neurological event prediction prediction tools and a systematic optimisation of pharmacological treatment. By covering and personalising the complete treatment pathway, Neurolytic Healthcare ensures improved quality of life and optimised clinical decision-making, whilst reducing the significant costs to the economy and healthcare system.

2018-19 cohort-07.png

Roman Rothärmel

DPhil Neuroscience

2018-19 cohort-14.png

Tom Kent

DPhil Medical Science

Artale

Art marketplace platform developing limited editions of art derivatives

The Chinese Authorised Art Derivatives market has an estimated size of 10 billion USD. Yet, it still has untapped opportunities. Artale addresses four primary issues faced by artists (lack of knowledge of how to monetise their art beyond galleries; lack of motivation to seek potential buyers; no market for the transactions of mid-tier artists’ works; and limited digital means to display and sell their art) and two issues faced by customers (middle income families do not have sufficient income to purchase high end artworks; and many potential customers are unaware of the range of offerings of the art market).

2018-19 cohort-08.png

Lucy Li

BA Economics and Management undergraduate

Lena Ma

MBA

2018-19 cohort-09.png

Helen Chan

British and European studies

Intrepidus

App using CBT to overcome the fear of needles

The current solutions to a fear of needs (talking therapies, distraction and relaxation) are either ineffective or expensive and inconvenient. Intrepidus provides convenient, low-cost, therapy-quality care to help people overcome their fear of needles. It does so via an app powered by AI and CBT which identifies and challenges patients’ fears and unhelpful thoughts and behaviours.

2018-19 cohort-15.png

Zaki Krag Nielsen

DPhil Medical Sciences

2018-19 cohort-16.png

Vlad Moldoveanu

MSc Mathematics and Computer Science

Ceres

Fresh pasta making robot

Ceres tackles the ‘hungry person’s trilemma’: when choosing between convenient, affordable and healthy food, you can generally have at most two of the three. This trilemma is most noteworthy during the lunchtime rush, which presents a lucrative opportunity: the lunchtime market in the UK is £5 billion per annum and growing.

Ceres is creating a high-end pasta making robot that can deliver a fresh pasta meal from order to service in less than 3 minutes.

Our Partners 2018/19

Our Advisors

We benefit from an incredible group of program advisors who help us shape the curriculum. Our advisors have a range of specialities and experiences relevant to the program.

Matt Clifford.jpeg

Matt Clifford

Co-Founder and CEO, Entrepreneur First

Tim Flagg Circle.png

Tim Flagg

Founder and CEO, Advantagious

Tom Pocock Circle.png

Tom Pocock

Co-Founder and CEO, AZTEC Protocol

Anthony Beaumont.png

Anthony Beaumont

Operations Director, Stake Zero Ventures

Our Workshop Partners

There are 10 workshops to help every team develop from idea to startup. They are split into 3 blocks: validation, build and growth. Every workshop is presented by one of our workshop partners, in the field of their expertise.

These workshops are very personal with only our cohort members being present, and give an opportunity to talk to the expert partners in great detail.

Matt Clifford.jpeg

Matt Clifford

Co-Founder and CEO, Entrepreneur First

Tim Flagg Circle.png

Tim Flagg

Founder and CEO, Advantagious

Edward Upton.jpeg

Edward Upton

Founder, Technical Lead and Product Consultant

Adnan Zaheer Circle.png

Adnan Zaheer

Founder and CEO, Seers Group

Paul Lindsell.png

Paul Lindsell

Founder and CEO, Thoughtspark

2018-19 mentors2-01.png

Irfan Mughal

CEO, Cipher

2018-19 mentors2-02.png

Tom Carrington-Smith

Product Lead, Entrepreneur First

2018-19 mentors2-03.png

Placi Espejo

Pitching Trainer

2018-19 mentors2-04.png

Meri Beckwith

Investment Manager, Oxford Capital

Our Mentors

OX1 gives you access to a large network of mentors. The majority of mentors will be confirmed after the selection process, with every one having relevant experience to the needs of the individual team. Every mentor will dedicate at least one hour per week to their team.

bas de vries.jpeg

Bas De Vries

Founder and CTO, Limbic

2018-19 mentors2-05.png

Niamh Gavin

EIR, Entrepreneur First

2018-19 mentors2-06.png

Huw Thomas

Founders of the Future

Tom Pocock Circle.png

Tom Pocock

Co-Founder and CEO, AZTEC Protocol

Camille Rougié

Co-Founder and CEO, Plural AI

Edward Upton.jpeg

Edward Upton

Founder, Technical Lead and Product Consultant, LittleData

2018-19 mentors2-07.png

Tom Bryan

EIR, Entrepreneur First